Cancer drugs tested for use against zoonotic bioweapons

04/7/2013 | FoxNews.com

Zoonotic illnesses such as monkeypox and Ebola are potential bioweapons, and the Defense Threat Reduction Agency is funding research into how two cancer medications -- Gleevec and Tasigna -- could serve as a defense against such attacks. The idea is that the drugs could slow an infection, allowing the immune system to mount an effective response. Scientists hope to develop a general defense against a variety of potential bioweapons because producing a separate drug for use against each agent is not practical.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC